.png){kind=small} | |
| Company type | Subsidiary |
|---|---|
| Industry | Healthcare, Information Services, Technology |
| Founded | 1954 as Information Medical Statistics |
| Fate | Merged with Quintiles to form IQVIA |
| Successor | IQVIA |
| Headquarters | Danbury, Connecticut, USA Durham, North Carolina, USA |
| Products | Healthcare Measurement, Analytics & Services, Consulting, Technology Services |
| Revenue | $2.64B[1] (2015) |
Number of employees | 14,000+[1] (2015) |
| Website | iqvia |
IMS Health was an American company that provided information, services and technology for the healthcare industry. IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data.[2][3][4] IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake.[5] In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners.[6] The company went public on April 4, 2014, and began trading on the NYSE under the symbol IMS.[1][7] IMS Health was headquartered in Danbury, Connecticut.
Over 2016 Quintiles and IMS Health merged, and the resulting company was named QuintilesIMS, which was renamed to IQVIA in 2017.
- ^ a b c IMS Health Annual Report (10-K), 2014
- ^ Steinbrook, R (Jun 29, 2006). "For sale: physicians' prescribing data". The New England Journal of Medicine. 354 (26): 2745–7. doi:10.1056/nejmp068125. PMID 16807410.
- ^ Fugh-Berman, A (August 2008). "Prescription tracking and public health". Journal of General Internal Medicine. 23 (8): 1277–80. doi:10.1007/s11606-008-0630-0. PMC 2517975. PMID 18473146.
- ^ Fugh-Berman, A; Ahari, S (April 2007). "Following the script: how drug reps make friends and influence doctors". PLOS Medicine. 4 (4): e150. doi:10.1371/journal.pmed.0040150. PMC 1876413. PMID 17455991.
- ^ "The Real Arthur Sackler. Part 4: Visionary Data Crook". 25 September 2019.
- ^ "IMS Health sold to TPG, CPPIB, LG&P"
- ^ Picker, Leslie (2014-04-04). "TPG-Backed IMS Health Gains After $1.3 Billion Share Sale". BloombergBusiness.